Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 23, Issue 7, Pages 829-837Publisher
SAGE PUBLICATIONS INC
DOI: 10.1097/01.WCB.0000071887.63724.B2
Keywords
cerebral blood flow; BOLD contrast; acetazolamide; arterial spin labeling; functional magnetic resonance imaging
Categories
Funding
- NIMH NIH HHS [5 P30 MH46971-09] Funding Source: Medline
- NINDS NIH HHS [R01 NS36722] Funding Source: Medline
Ask authors/readers for more resources
The authors studied the effects of altering global cerebral blood flow on both blood oxygen level-dependent (BOLD) response and perfusion response to finger-thumb apposition. A PICORE/QUIPSS II protocol was used to collect interleaved BOLD-weighted and perfusion-weighted images on eight finger-thumb apposition trials. Subjects were studied on a drug-free day and on a day when acetazolamide was administered between the second and third trials. After acetazolamide administration, resting cortical per-fusion increased an average of 20% from preadministration levels, whereas the BOLD response to finger-thumb apposition decreased by an average of 35% in the S1M1 hand area. Contrary to predictions from the exhausted cerebrovascular reserve hypothesis and the oxygen limitation model, an effect of acetazolamide on cerebral blood flow response in the S I M I hand area was not observed. Across the acetazolamide trials, BOLD response was inversely correlated with resting cortical perfusion for individual subject data. These results suggest that resting perfusion affects the magnitude of the BOLD response and is thus an important confounding factor in fMRI studies, and that the physiologic systems that increase cerebral blood flow in response to acetazolamide administration and systems that increase cerebral blood flow in response to altered neural activity appear to have additive effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available